Evidence map›Paper›PMID 25723140›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2015

Antiretroviral Treatment Is Associated With Iron Deficiency in HIV-Infected Malawian Women That Is Mitigated With Supplementation, but Is Not Associated With Infant Iron Deficiency During 24 Weeks of Exclusive Breastfeeding.

Elizabeth M Widen, Margaret E Bentley, Charles S Chasela, Dumbani Kayira, Valerie L Flax, Athena P Kourtis, Sascha R Ellington, Zebrone Kacheche, Gerald Tegha, Denise J Jamieson and 5 more

Erratum issuedOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Elizabeth M Widen*Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; †Department of Nutrition, University of Witwatersrand, Parktown, South Africa; ‡Faculty of Health Sciences,UNC Project, Lilongwe, Malawi; §Division of Reproductive Health, US Centers for Disease Control and Prevention, Atlanta, GA; and #US Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA.
Margaret E Bentley
Charles S Chasela
Dumbani Kayira
Valerie L Flax
Athena P Kourtis
Sascha R Ellington
Zebrone Kacheche
Gerald Tegha
Denise J Jamieson
Charles M van der Horst
Lindsay H Allen
Setareh Shahab-Ferdows
Linda S Adair
BAN Study Team
University of North Carolina at Chapel Hill · USCenters for Disease Control and Prevention · USAgricultural Research Service · USUniversity of the Witwatersrand · ZAWestern Human Nutrition Research Center · US

Funding

Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
UNC Center for Health Promotion and Disease PreventionU48DP000059 · DP · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AMMERMAN, ALICE S · 2004 to 2009
$14.4M
Carolina Population CenterR24HD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MORGAN, SAMUEL PHILIP · 2005 to 2014
$10.0M
AIDS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW001039 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADIMORA, ADAORA A · 1998 to 2013
$9.9M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
The Feasibility of Replacement Feeding as an HIV Prevention Method in MalawiR03HD057775 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BENTLEY, MARGARET E · 2007 to 2008
$141k
Prenatal Nutrition and Adverse Birth Outcomes in HIV-Infected Women in MalawiR03HD057637 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ADAIR, LINDA S · 2007 to 2007
$71k
ACL HHS U48DP001944FIC NIH HHS 2-D43TW01039-06FIC NIH HHS D43 TW001039FIC NIH HHS R24 TW007988NCCDPHP CDC HHS SIP 22-09 U48-DP001944-01NCCDPHP CDC HHS SIP 26-04 U48-DP000059-01NCCDPHP CDC HHS U48 DP000059NIAID NIH HHS P30 AI050410NIAID NIH HHS P30-AI50410NICHD NIH HHS P2C HD050924NICHD NIH HHS R03 HD057637NICHD NIH HHS R03 HD057775NICHD NIH HHS R24 HD050924PHS HHS SIP 13-01 U48-CCU409660-09
6 · The paper itself

Abstract

objectiveIn resource-limited settings without safe alternatives to breastfeeding, the WHO recommends exclusive breastfeeding and antiretroviral (ARV) prophylaxis. Given the high prevalence of anemia among HIV-infected women, mothers and their infants (through fetal iron accretion) may be at risk of iron deficiency. We assessed the effects of maternal micronutrient-fortified lipid-based nutrient supplements (LNS) and maternal ARV treatment or infant ARV prophylaxis on maternal and infant iron status during exclusive breastfeeding from birth to 24 weeks.

methodsThe Breastfeeding, Antiretrovirals, and Nutrition study was a randomized controlled trial conducted in Lilongwe, Malawi, from 2004 to 2010. HIV-infected mothers (CD4 >200 cells/μL) and their infants were randomly assigned to 28-week interventions: maternal LNS/maternal ARV (n = 424), maternal LNS/infant ARV (n = 426), maternal LNS (n = 334), maternal ARV (n = 425), infant ARV (n = 426), or control (n = 334). Longitudinal models tested intervention effects on hemoglobin (Hb). In a subsample (n = 537) with multiple iron indicators, intervention effects on Hb, transferrin receptors (TfR), and ferritin were tested with linear and Poisson regression.

resultsIn longitudinal models, LNS effects on maternal and infant Hb were minimal. In subsample mothers, maternal ARVs were associated with tissue iron depletion (TfR >8.3 mg/L) (risk ratio: 3.1, P < 0.01), but not in ARV-treated mothers receiving LNS (P = 0.17). LNS without ARVs was not associated with iron deficiency or anemia (P > 0.1). In subsample infants, interventions were not associated with impaired iron status (all P > 0.1).

conclusionsMaternal ARV treatment with protease inhibitors is associated with maternal tissue iron depletion; but LNS mitigates adverse effects. ARVs do not seem to influence infant iron status; however, extended use needs to be evaluated.

Indexed as

Breast FeedingDietary SupplementsIron DeficienciesAnti-HIV AgentsDrug Administration ScheduleFemaleHemoglobinsHIV InfectionsHumansInfantInfant, NewbornIronIron, DietaryLongitudinal StudiesMalawiMaleAnti-HIV AgentsHemoglobinsIronIron, Dietary

Identifiers

PMID25723140
PMCPMC4506710
OpenAlexW2001932318

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.